Workflow
南京健友生化制药股份有限公司关于“健友转债”转股结果暨股份变动的公告

Core Viewpoint - The announcement details the conversion results of the "Jianyou Convertible Bonds" and the changes in the company's share capital as of June 30, 2025, highlighting the low conversion rate and the significant amount of unconverted bonds [1][2][3]. Summary by Sections Conversion Situation - As of June 30, 2025, a total of RMB 719,000 worth of "Jianyou Convertible Bonds" has been converted into common shares, resulting in 18,035 shares, which represents 0.001% of the total shares before conversion [2][6]. - The total amount of "Jianyou Convertible Bonds" that has not been converted is RMB 502,464,000, accounting for 99.86% of the total issuance [3][6]. Convertible Bond Issuance Overview - The company issued 5,031,900 convertible bonds with a total value of RMB 503.19 million, with a maturity of 6 years, approved by the China Securities Regulatory Commission [4]. - The bonds were listed on the Shanghai Stock Exchange on May 22, 2020, under the code "113579" [4]. Conversion Price Adjustments - The initial conversion price was set at RMB 54.97 per share, which has been adjusted multiple times due to various corporate actions, with the latest adjustment bringing the price to RMB 24.34 per share as of June 5, 2025 [5].